WinstonWınston
Back

This stock no longer trades (delisted March 21, 2024)

Delisted / no longer publicly traded (per market data provider) Everything below is based on the last available data — treat it as historical, not a live read.

Stock

Orpea S.A.

0NEX.L
40
Medical - Care Facilities · Healthcare
Price
22.90 GBp
-0.09 (-0.40%)
Market Cap
£3.69B
Exchange
London Stock Exchange
Winston Score
40
Historical score — this stock no longer trades, so the score is frozen at the last available data.
Data as of Oct 9, 2026 · filings through Jun 30, 2024

§How the score breaks down

Quality
Mixed
10/30
Growth
Mixed
5/20
Cash Flow
Weak
1/10
Stability
Mixed
4/10
Valuation
Good
6/10
Ownership
Good
10/15
Dividends
Strong
4/5

40 of 100 counted points = Winston Score 40.

Share count rising — dilution

+19.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.3M (2019) → 1.6M (2023)

§Winston Score History

The full picture

Orpea is a French company that runs nursing homes, assisted-living facilities, and rehabilitation clinics for elderly and vulnerable people across Europe and beyond. Its main customers are older adults who need daily care, medical support, or help recovering from illness or surgery. Orpea was once one of the largest private care-home operators in the world by number of beds.

The company earns money by charging residents and their families — or government health programs — fees for room, board, and medical care. It operates thousands of facilities across France, Germany, Belgium, Poland, and several other countries. Orpea went through a severe financial and reputational crisis after a 2022 book alleged widespread neglect and financial mismanagement, forcing a major debt restructuring that wiped out most original shareholders. The key challenge going forward is rebuilding trust, restoring profitability from its very thin margins, and managing the heavy debt load that remains after restructuring.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+40.6% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

€0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

37.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€790M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Orpea S.A. is growing revenue at 9% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
0.3%
Thin — 0.3% gross margin
Profit after running costs
Operating Margin
-0.1%
Losing money on operations — -0.1%
Return on the money invested
ROCE
24.4%
Exceptional — 24.4% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+10.2%
Steady sales growth (+10.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
23%
Weak — only 23% of profit becomes cash
Spare cash per sale
FCF Margin
-3.8%
Burning cash (-3.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
4.65
Heavy debt load (4.65)
Covers its interest
Interest Cover
13.18x
Comfortably covers interest (13.2x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
0.0x
Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.93%
Moderate income — 3.93% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
+40.0%
Dividend growing fast (40.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial